Drug intelligence / Profile preview

measles virus vaccine live (Merck & Co.)

Development stage
Unknown
Lead developer
Merck
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

Measles virus vaccine live is a live-attenuated viral vaccine used for active immunization to prevent measles (rubeola) infection. The vaccine contains a weakened, non-pathogenic strain of the measles virus (typically derived from the Enders' attenuated Edmonston strain, such as the Moraten or Schwarz strains) propagated in chick embryo cell cultures. Upon administration, the live-attenuated virus replicates in host cells, mimicking a natural infection without causing severe disease. This replication stimulates a robust, long-lasting immune response, including the production of neutralizing antibodies and the activation of T-cell-mediated immunity, which provides protective immunity against future exposure to wild-type measles virus.

Brand names
Attenuvax
Other names
live attenuated measles vaccinemeasles attenuated vaccine virusmeasles vaccinemeasles vaccine livemeasles virus vaccine live, attenuated
02

Targets

SLAMF1 (SLAM family member 1)CD46 (CD46 Molecule)PVRL4 (Nectin cell adhesion molecule 4)

Beyond the preview

Go deeper on measles virus vaccine live (Merck & Co.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on measles virus vaccine live (Merck & Co.).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call